Á¦ ¸ñ 2019³â ´ëÇѾÏÇÐȸ Çмú»ó ¼ö»óÀÚ
ÀÛ¼ºÀÚ ÇÐȸ°ü¸®ÀÚ ÀÛ¼ºÀÏ 2019-07-08
÷ ºÎ ÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù. Á¶ ȸ 3073
<style type="text/css"><!--
a{text-decoration:none;
transition: all 0.4s;
}
a:hover{
color:#0666b0;
background-color: #f4e0c1;
}
--></style>
<table style="width: 1118px;" cellspacing="2" cellpadding="5">
<tbody>
<tr>
<td height="104" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"><strong style="font-size: 25px;">2019³â ´ëÇѾÏÇÐȸ Çмú»ó ¼ö»óÀÚ ¸í´Ü</strong></td>
</tr>
<tr>
<td height="30" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"></td>
</tr>
<tr>
<td style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"><strong>1. Á¦ 11ȸ ´ëÇѾÏÇÐȸ ±âÃÊ¿ì¼ö³í¹®»ó (CRT¿¡ °ÔÀçµÈ ±âÃÊ³í¹®, »ó±Ý °¢ 250¸¸¿ø)</strong></td>
</tr>
<tr align="center" bgcolor="#acacac">
<td width="50" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>No.</strong></td>
<td width="280" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>¼ö»óÀÚ</strong></td>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>Á¦ ¸ñ</strong></td>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>ÆäÀÌÁö¹øÈ£</strong></td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">1</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">À̺´¶õ (¼­¿ïÀÇ´ë ÇغÎÇб³½Ç)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2016.580" target="_blank">FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(1)239-254</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">2</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">¾ç¹ÌÈñ (¼÷¸í¿©´ë ¾àÇдëÇÐ)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.001" target="_blank">Proteomic Biomarkers for Bisphenol A–Early Exposure and Women’s Thyroid Cancer <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(1)111-117</td>
</tr>
<tr>
<td height="30" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"></td>
</tr>
<tr>
<td style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"><strong>2. Á¦ 9ȸ ¸ÓÅ© ¾ÏÇмú»ó (CRT¿¡ °ÔÀçµÈ ÀÓ»ó³í¹® Áß ´ëÀå¾Ï ¶Ç´Â µÎ°æºÎ ³í¹®, »ó±Ý °¢ 200¸¸¿ø)</strong></td>
</tr>
<tr align="center" bgcolor="#acacac">
<td width="”100”" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>No.</strong></td>
<td width="280" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>¼ö»óÀÚ</strong></td>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>Á¦ ¸ñ</strong></td>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>ÆäÀÌÁö¹øÈ£</strong></td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">1</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">Ãֱͼ± (±¹¸³¾Ï¼¾ÅÍ ¾Ï°ËÁø»ç¾÷°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.075" target="_blank">Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(2)416-427</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">2</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">ÀÌÀÎ±Ô (°¡Å縯ÀÇ´ë¿Ü°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.194" target="_blank">Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National Data <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(4)1149-1163</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">3</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">ÀåÈ«¼® (°¡Å縯ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.252" target="_blank">The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(3)1039-1050</td>
</tr>
<tr>
<td height="30" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"></td>
</tr>
<tr>
<td style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"><strong>3. Á¦ 11ȸ ·Î½´ ¾ÏÇмú»ó (CRT¿¡ °ÔÀçµÈ ÀÓ»ó & Translational ³í¹® 10Æí, »ó±Ý °¢ 200¸¸¿ø)</strong></td>
</tr>
<tr align="center" bgcolor="#acacac">
<td width="”100”" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>No.</strong></td>
<td width="280" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>¼ö»óÀÚ</strong></td>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>Á¦ ¸ñ</strong></td>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>ÆäÀÌÁö¹øÈ£</strong></td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">1</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">¹æ¿µÁÖ (¼­¿ïÀÇ´ë ³»°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.303" target="_blank">Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(3)835-842</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">2</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">¾ç½ÂÈ£ (°¡Å縯ÀÇ´ë ½Å°æ¿Ü°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.466" target="_blank">High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(4)1331-1342</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">3</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">Àӹΰæ (±¹¸³¾Ï¼¾ÅÍ ¾Ï¿¹¹æ»ç¾÷°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.174" target="_blank">Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(2)436-444</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">4</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">¹Ú¼ö°æ (¼­¿ïÀÇ´ë ¿¹¹æÀÇÇб³½Ç)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.048" target="_blank">Effectiveness of Gastric Cancer Screening on Gastric Cancer Incidence and Mortality in a Community-Based Prospective Cohort <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(2)582-589</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">5</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">¼­µ¿Ã¶ (Áß¾Ó´ëÇб³ ¾àÇдëÇÐ)/ ±è¿­È« (°í·ÁÀÇ´ë ³»°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2016.535" target="_blank">Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(1)175-182</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">6</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">±è½Å¹Ì (â¿ø´ëÇб³ °£È£´ëÇÐ)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2016.446" target="_blank">Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(2)614-623</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">7</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">¸í½Â±Ç (±¹¸³¾Ï¼¾ÅÍ ¾Ï¿¹¹æ°ËÁø¼¾ÅÍ)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.094" target="_blank">Light Alcohol Drinking and Risk of Cancer: A Meta-Analysis of Cohort Studies <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(2)474-487</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">8</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">³²ÀºÁö (¿¬¼¼ÀÇ´ë »êºÎÀΰú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2017.220" target="_blank">Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2 <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(3)917-925</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">9</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">ÀÓÈ£¿µ (»ï¼º¼­¿ïº´¿ø ³»°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2016.584" target="_blank">Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(2)488-494</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">10</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">±èÁø±¹ (»ï¼º¼­¿ïº´¿ø ÈäºÎ¿Ü°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://doi.org/10.4143/crt.2016.591" target="_blank">Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">(1)95-102</td>
</tr>
<tr>
<td height="30" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"></td>
</tr>
<tr>
<td style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"><strong>4. Á¦ 8ȸ ±¤µ¿¾ÏÇмú»ó</strong></td>
</tr>
<tr>
<td style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#eeeeee" colspan="4">  SCI Àú³Î¿¡ ¹ßÇ¥ µÈ ³í¹® Áß CRTÀú³ÎÀÇ IF Çâ»ó¿¡ ±â¿©ÇÑ ³í¹®ÀÇ Ã¥ÀÓ ÀúÀÚ (±âÃÊ, Áß°³ ¹× ÀÓ»ó, ´Ù¼ö ¹ßÇ¥)</td>
</tr>
<tr align="center" bgcolor="#acacac">
<td width="”100”" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>No.</strong></td>
<td width="180" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>ÀúÀÚ ¹× ¼Ò¼Ó</strong></td>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>³í¹®Á¦¸ñ</strong></td>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>°ÔÀçÇмúÁö</strong></td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">1</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">±èöȣ (¾ÆÁÖÀÇ´ë À̺ñÀÎÈÄ°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915028/" target="_blank">HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /> </a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">Autophagy. 2018;14(3):385-403</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">2</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">ÃÖÀÏÁÖ (±¹¸³¾Ï¼¾ÅÍ ³»°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://www.nejm.org/doi/10.1056/NEJMoa1708423" target="_blank">Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">N Engl J Med. 2018;378(12):1085-95</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">3</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">ÀüÀç°ü (±¹¸³¾Ï¼¾ÅÍ ¾Ï°ËÁø»ç¾÷°ú)</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3"><a href="https://insights.ovid.com/crossref?an=00000434-201804000-00023" target="_blank">Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea <img title="Fulltext HTML file" style="vertical-align: middle;" src="http://www.e-crt.org/image/button/fulltext.gif" border="0" /></a></td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">Am J Gastroenterol. 2018;113(4):611621.</td>
</tr>
<tr>
<td height="30" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"></td>
</tr>
<tr>
<td style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" colspan="4"><strong>5. Á¦11ȸ ´ëÇѾÏÇÐȸÁö Best Reviewer»ó (4¸í ¼±Á¤, »ó±Ý °¢ 50¸¸¿ø)</strong></td>
</tr>
<tr>
<td style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#eeeeee" colspan="4">  : 2018³â 1¿ù ~12¿ù±îÁö ½É»çÇÑ À§¿øÀ¸·Î ½É»ç±â°£À» ÁؼöÇÏ°í, ½É»çÀÇ °´°ü¼º, Ÿ´ç¼º, °Ç¼³ÀûÀÎ ÀÇ°ßÀ¸·Î ³í¹®ÀÇ ÁúÀû Çâ»ó¿¡ ±â¿©ÇÑ ½É»çÀ§¿ø ¼±Á¤</td>
</tr>
<tr align="center" bgcolor="#acacac">
<td width="”100”" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>No.</strong></td>
<td width="280" align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#acacac"><strong>¼ö»óÀÚ</strong></td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3" rowspan="1">1</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">±è¿ì¿µ (¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3" rowspan="1">2</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">±èÁ¾±¤ (°æºÏÀÇ´ë ³»°ú)</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3" rowspan="1">3</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">±èŹΠ(¼­¿ïÀÇ´ë ³»°ú)</td>
</tr>
<tr>
<td align="center" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3" rowspan="1">4</td>
<td align="left" style="font-family: '³ª´®°íµñ','¸¼Àº °íµñ';" bgcolor="#f3f3f3">ÇÑÁö¿¬ (±¹¸³¾Ï¼¾ÅÍ ³»°ú)</td>
</tr>
</tbody>
</table>
<p></p>
<p></p>
<p></p>